Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rang in Aktien #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Aktienkurs
$115.67
Marktkapitalisierung
$285.98B
Veränderung (1 Tag)
1.30%
Veränderung (1 Jahr)
25.31%
Land
US
Handel Merck & Co., Inc. (MRK)

Kategorie

P/B-Verhältnis für Merck & Co., Inc. (MRK)
P/B-Verhältnis zum March 2026 TTM: 5.47
Laut den neuesten Finanzberichten und dem Aktienkurs von Merck & Co., Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 5.47. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 5.44.
P/B-Verlauf für Merck & Co., Inc. von 2000 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 5.47 7.73%
2025 5.08 -6.51%
2024 5.44 -28.09%
2023 7.56 23.82%
2022 6.11 20.29%
2021 5.08 -34.85%
2020 7.79 -9.22%
2019 8.59 21.37%
2018 7.07 67.90%
2017 4.21 9.48%
2016 3.85 22.74%
2015 3.14 -0.75%
2014 3.16 12.54%
2013 2.81 25.96%
2012 2.23 11.14%
2011 2.01 2.50%
2010 1.96 57.27%
2009 1.24 -62.32%
2008 3.30 -50.09%
2007 6.61 28.29%
2006 5.16 39.08%
2005 3.71 -5.78%
2004 3.93 -37.81%
2003 6.33 -5.53%
2002 6.70 -16.24%
2001 7.99 -42.42%
2000 13.88 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
33.3372 509.18%
US
6.0657 10.84%
GB
7.1931 31.44%
US
-119.6075 -2,285.61%
US
6.3334 15.73%
CH